---
id: "entity-triomics"
type: "entity"
entityType: "tool"
canonicalName: "Triomics"
aliases: []
source_timestamps: ["§ 3. Use strategic partnerships to unlock the value of AI in drug discovery and development.", "¶14"]
tags: ["software", "clinical-trials"]
related: ["concept-in-house-accelerators"]
sources: ["tail2"]
sourceVaultSlug: "hbr-seg-tail2"
originDay: 2
articleStem: "hbr-tail-131-medical-drug-discovery"
sourceUrl: "https://hbr.org/2026/04/u-s-medical-centers-need-a-new-model-for-drug-discovery-and-development"
sourceTitle: "U.S. Medical Centers Need a New Model for Drug Discovery and Development"
---
# Triomics

A technology platform used to **match cancer patients to appropriate clinical trials in real time**, demonstrating the value of AI partnerships in optimizing trial enrollment (Pillar 3 of the [[framework-amc-innovation-acceleration]]).

**Enrichment context:** canonical context is **real-time trial matching and enrollment optimization in cancer care** — part of a broader movement to reduce recruitment bottlenecks in oncology and rare disease. The extraction's description should be confirmed from the company's own materials.